ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY
Stefan Schreiber 1
Corey A Siegel 2
Keith Friedenberg 3
Ursula Seidler 4
Bal R. Bhandari 5
Ziad Younes 6
KE WANG 7
Matthew McKevitt
Sally Zhao
Bittoo Kanwar
John Sundy
Scott D. Lee
Edward V Loftus Jr
1 Christian-Albrechts-University Kiel,Kiel,Germany
2 Dartmouth-Hitchcock Medical Center,Lebanon,United States of America
3 Great Lakes Gastroenterology,Mentor,United States of America
4 Hannover Medical School,Hannover,Germany
5 Delta Research Partners,Monroe,United States of America
6 GastroOne,Germantown,United States of America
7 Gilead S
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu